ECYT - Endocyte

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Tue 14'th Aug 2018

PERIOD 2018-05-15 - 2018-08-14
CHANGE 3.48%
PRICE $16.35





Request Prediction

Endocyte Stock Analysis

Technical stock analysis for Tue 14'th Aug 2018

Buy candidate since 2018-08-14
Shorts 7.44% ( 2018-07-31 )
Cash 103.1 mill
Loans n/a
Beta 0.13
ROA -35.36

Endocyte gained 3.48% in the last trading day, rising from $15.80 to $16.35 The price has risen in 6 of the last 10 days and is up by 6.72% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 236 367 more shares were traded than the day before. In total, 746 354 shares bought and sold for approximately $12.20 million.


Endocyte lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 23.07% during the next 3 months and, with 90% probability hold a price between $18.71 and $22.91 at the end of this period.

Click here for today's Top 5 Trending Companies


Only positive signals in the chart today. Endocyte holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $16.05 and $15.82. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday August 13, 2018, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

A sell signal from a double top formation was found on Thursday August 09, 2018 and based on theory for this formation the price should fall by -0.56% to $15.74 within 5 trading days since signal was issued (Thursday August 16, 2018).

Relative Strength Index (RSI)

RSI14 is 62 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $14.45 and $13.79.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Endocyte finds support just below today's level at $14.45. If this is broken, then the next support from accumulated volume will be at $13.79 and $13.51.

Support: $14.45 Price: $16.35 Resistance: $16.46


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.89 between high and low, or 5.68%. For the last week, the stock has had a daily average volatility of 4.04%.

Our recommended stoploss: $15.55 (-4.92%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High


Endocyte holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Strong Buy Candidate.

Strong Buy Candidate

Click for Top 5 Strong Buy Candidates
ECYT $16.35 $0.55(3.48%)
ECYT is up $0.55 today, but where's it headed in September?
Zacks Investment Research is releasing its prediction for ECYT based on the 1-3 month system that more than doubles the S&P 500.

Click here – the ECYT analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with